AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 35807864 — intervention group
Group type: COMPARATOR
Intervention: Ethanol vehicle control (in vitro)
Number of subjects: 10
Study 33188400 — intervention group
Group type: EXPERIMENTAL
Intervention: INTε4+
Number of subjects: 188
Study 33188400 — intervention group
Group type: EXPERIMENTAL
Intervention: INT (all groups)
Number of subjects: 188
Study 33049455 — intervention group
Group type: EXPERIMENTAL
Intervention: Appearance Teasing & Bullying animation
Number of subjects: 1329
Study 33049455 — intervention group
Group type: EXPERIMENTAL
Intervention: Media & Celebrities animation
Number of subjects: 1329
Study 33049455 — intervention group
Group type: COMPARATOR
Intervention: Non-appearance-related animation
Number of subjects: 1329
Study 33049455 — intervention group
Group type: EXPERIMENTAL
Intervention: All animations (for girls and boys aged 7-10)
Number of subjects: 1329
Study 36314323 — intervention group
Group type: EXPERIMENTAL
Intervention: CIRRHOS product (2 gr L-carnitine and 150 mg magnesium) for 16 weeks
Number of subjects: 22
Study 36314323 — intervention group
Group type: COMPARATOR
Intervention: Placebo for the first 8 weeks and CIRRHOS product for an additional 8 weeks
Number of subjects: 22
Study 33851684 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance Training (RT) for obese individuals
Number of subjects: 225
Study 33851684 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance Training (RT) for average-weight individuals
Number of subjects: 225
Study 33851684 — intervention group
Group type: COMPARATOR
Intervention: No Resistance Training for obese individuals
Number of subjects: 225
Study 37604396 — intervention group
Group type: EXPERIMENTAL
Intervention: Lozenge containing 2% arginine and probiotics (Lacticaseibacillus rhamnosus, LGG® and Lactobacillus paracasei subsp. paracasei)
Number of subjects: 288
Study 37604396 — intervention group
Group type: COMPARATOR
Intervention: Placebo lozenge
Number of subjects: 288
Study 33549047 — intervention group
Group type: EXPERIMENTAL
Intervention: Fecal microbiota transplantation (FMT) capsules, administered once a week for 4 consecutive weeks
Number of subjects: 55
Study 33549047 — intervention group
Group type: COMPARATOR
Intervention: Placebo capsules, administered once a week for 4 consecutive weeks
Number of subjects: 55
Study 33549047 — intervention group
Group type: EXPERIMENTAL
Intervention: Fecal microbiota transplantation (FMT) capsules
Number of subjects: 55
Study 33549047 — intervention group
Group type: COMPARATOR
Intervention: Placebo capsules
Number of subjects: 55
Study 32140867 — intervention group
Group type: EXPERIMENTAL
Intervention: Morning administration of IFN‐β1a 44 µg (Rebif)
Number of subjects: 200
Study 32140867 — intervention group
Group type: COMPARATOR
Intervention: Evening administration of IFN‐β1a 44 µg (Rebif)
Number of subjects: 200
Study 35822289 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral contraceptives (OC) during hypercapnia
Number of subjects: 26
Study 35822289 — intervention group
Group type: COMPARATOR
Intervention: Not taking oral contraceptives (NOC) during hypercapnia
Number of subjects: 26
Study 35822289 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypercapnia in all women
Number of subjects: 26
Study 35822289 — intervention group
Group type: COMPARATOR
Intervention: Low frequency (LF) Phase in NOC-HH
Number of subjects: 26
Study 35822289 — intervention group
Group type: COMPARATOR
Intervention: Low frequency (LF) Phase in OC-LH
Number of subjects: 26
Study 32565041 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous Quality Improvement (CQI) approach with Safety Planning Intervention (SPI)
Number of subjects: 0
Study 32565041 — intervention group
Group type: COMPARATOR
Intervention: Baseline (retrospective)
Number of subjects: 0
Study 36376830 — intervention group
Group type: EXPERIMENTAL
Intervention: Silicate‐based fluoride toothpaste: REFIX technology, regenerador + sensitive (RDC)
Number of subjects: 60
Study 36376830 — intervention group
Group type: EXPERIMENTAL
Intervention: Arginine‐containing toothpaste, Colgate Total Daily Repair (PC)
Number of subjects: 60
Study 36376830 — intervention group
Group type: EXPERIMENTAL
Intervention: Silicate‐based fluoride toothpaste: NR-5 technology, Regenerate Enamel Science (RES)
Number of subjects: 60
Study 36376830 — intervention group
Group type: EXPERIMENTAL
Intervention: Silicate‐based fluoride toothpaste: NOVAMIN technology, Sensodyne Repair and Protect (SRP)
Number of subjects: 60
Study 36376830 — intervention group
Group type: COMPARATOR
Intervention: Fluoride‐free toothpaste, Colgate Oral Care (NC)
Number of subjects: 60
Study 34087413 — intervention group
Group type: EXPERIMENTAL
Intervention: Oblique NFLJI
Number of subjects: 0
Study 34087413 — intervention group
Group type: EXPERIMENTAL
Intervention: Perpendicular NFLJI
Number of subjects: 0
Study 34087413 — intervention group
Group type: COMPARATOR
Intervention: Needle injections
Number of subjects: 0
Study 33239944 — intervention group
Group type: EXPERIMENTAL
Intervention: Inertial Group (IG) - accentuated eccentric training using a rotary inertial device
Number of subjects: 54
Study 33239944 — intervention group
Group type: COMPARATOR
Intervention: Plyometric Group (PG) - plyometric exercises
Number of subjects: 54
Study 35606570 — intervention group
Group type: EXPERIMENTAL
Intervention: Incredible Years (TIY) parenting education
Number of subjects: 164
Study 35606570 — intervention group
Group type: COMPARATOR
Intervention: Control group (EHS without TIY)
Number of subjects: 164
Study 32232363 — intervention group
Group type: EXPERIMENTAL
Intervention: Glucagon (2 pmol/kg/min intravenous infusion)
Number of subjects: 18
Study 32232363 — intervention group
Group type: COMPARATOR
Intervention: Vehicle infusion (rate-matched)
Number of subjects: 18
Study 32367175 — intervention group
Group type: EXPERIMENTAL
Intervention: 12-week supervised exercise training program
Number of subjects: 49
Study 32367175 — intervention group
Group type: COMPARATOR
Intervention: Control group (no exercise training)
Number of subjects: 49
Study 34597539 — intervention group
Group type: EXPERIMENTAL
Intervention: Machine learning model using LASSO regression
Number of subjects: 8501
Study 34597539 — intervention group
Group type: EXPERIMENTAL
Intervention: Linear model
Number of subjects: 8501
Study 33187503 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypnotherapeutic group program (5 weekly sessions of 120-min duration, plus 5 hypnosis audiorecords for individual practice at home, plus an educational booklet for stress coping)
Number of subjects: 95
Study 33187503 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypnotherapeutic group program
Number of subjects: 95
Study 33187503 — intervention group
Group type: COMPARATOR
Intervention: Control group (educational booklet only)
Number of subjects: 95
Study 33187503 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 95
Study 36184254 — intervention group
Group type: EXPERIMENTAL
Intervention: Glucose supplementation (intervention group)
Number of subjects: 44
Study 36184254 — intervention group
Group type: COMPARATOR
Intervention: Fructose supplementation (control group)
Number of subjects: 44
Study 33227157 — intervention group
Group type: EXPERIMENTAL
Intervention: MIM DASH
Number of subjects: 0
Study 33227157 — intervention group
Group type: COMPARATOR
Intervention: Attention only (non‐hypertensive education)
Number of subjects: 0
Study 33227157 — intervention group
Group type: COMPARATOR
Intervention: True control group
Number of subjects: 0
Study 35450813 — intervention group
Group type: EXPERIMENTAL
Intervention: PCAT attenuation of the right coronary artery (RCA)
Number of subjects: 1697
Study 35450813 — intervention group
Group type: EXPERIMENTAL
Intervention: LAP burden >4%
Number of subjects: 1697
Study 35450813 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of PCAT-RCA of ≥−70.5 HU and LAP burden >4%
Number of subjects: 1697
Study 35450813 — intervention group
Group type: EXPERIMENTAL
Intervention: LAP burden
Number of subjects: 1697
Study 35450813 — intervention group
Group type: EXPERIMENTAL
Intervention: PCAT attenuation
Number of subjects: 1697
Study 35450813 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of LAP burden and PCAT attenuation
Number of subjects: 1697
Study 33760643 — intervention group
Group type: EXPERIMENTAL
Intervention: Individualized homeopathy (IH)
Number of subjects: 68
Study 33760643 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 68
Study 36037272 — intervention group
Group type: EXPERIMENTAL
Intervention: CAD/CAM orthoses and night splint
Number of subjects: 34
Study 36037272 — intervention group
Group type: COMPARATOR
Intervention: Night splint only
Number of subjects: 34
Study 33586596 — intervention group
Group type: EXPERIMENTAL
Intervention: 15-method
Number of subjects: 10
Study 34365136 — intervention group
Group type: EXPERIMENTAL
Intervention: Grade 3 ischemia (G3I)
Number of subjects: 7211
Study 34365136 — intervention group
Group type: COMPARATOR
Intervention: Grade 2 ischemia (G2I)
Number of subjects: 7211
Study 37294244 — intervention group
Group type: EXPERIMENTAL
Intervention: Dapagliflozin
Number of subjects: 6263
Study 37294244 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6263
Study 34426025 — intervention group
Group type: EXPERIMENTAL
Intervention: Cluster randomized ring vaccination
Number of subjects: 0
Study 34426025 — intervention group
Group type: EXPERIMENTAL
Intervention: Cluster randomized mass vaccination
Number of subjects: 0
Study 34426025 — intervention group
Group type: EXPERIMENTAL
Intervention: Observational case-control study design
Number of subjects: 0
Study 32942203 — intervention group
Group type: EXPERIMENTAL
Intervention: Mind-OP intervention (n = 227)
Number of subjects: 456
Study 32942203 — intervention group
Group type: COMPARATOR
Intervention: Control condition (n = 229)
Number of subjects: 456
Study 35627704 — intervention group
Group type: EXPERIMENTAL
Intervention: Kitchen diet (n = 32; 1.2 g fiber in 100 mL)
Number of subjects: 59
Study 35627704 — intervention group
Group type: COMPARATOR
Intervention: Nutrison Energy® (n = 14; 0.02 g fiber in 100 mL)
Number of subjects: 59
Study 35627704 — intervention group
Group type: COMPARATOR
Intervention: Nutrison Diason Energy HP® (n = 13; 1.8 g fiber in 100 mL)
Number of subjects: 59
Study 34950068 — intervention group
Group type: EXPERIMENTAL
Intervention: Compassion Cultivation Training (CCT)
Number of subjects: 161
Study 33778907 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraoperative blood cell salvage and autotransfusion (IBSA)
Number of subjects: 110
Study 33778907 — intervention group
Group type: COMPARATOR
Intervention: Non-IBSA
Number of subjects: 110
Study 33002888 — intervention group
Group type: EXPERIMENTAL
Intervention: GLB + LGx
Number of subjects: 140
Study 33002888 — intervention group
Group type: COMPARATOR
Intervention: GLB
Number of subjects: 140
Study 34903039 — intervention group
Group type: EXPERIMENTAL
Intervention: Semaglutide/liraglutide
Number of subjects: 12637
Study 34903039 — intervention group
Group type: EXPERIMENTAL
Intervention: Semaglutide 1.0 mg
Number of subjects: 12637
Study 34903039 — intervention group
Group type: EXPERIMENTAL
Intervention: Liraglutide
Number of subjects: 12637
Study 32768938 — intervention group
Group type: EXPERIMENTAL
Intervention: Yidu-toxicity blocking lung decoction (ICW group)
Number of subjects: 40
Study 32768938 — intervention group
Group type: COMPARATOR
Intervention: Pure western medicine therapy (PWM group)
Number of subjects: 40
Study 32768938 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 40
Study 33253756 — intervention group
Group type: EXPERIMENTAL
Intervention: Routine Fundus Photography (RFP)
Number of subjects: 1447
Study 33253756 — intervention group
Group type: COMPARATOR
Intervention: Standard Care
Number of subjects: 1447
Study 35263343 — intervention group
Group type: EXPERIMENTAL
Intervention: Lipid-based nutrient supplement (LNS)
Number of subjects: 1609
Study 35263343 — intervention group
Group type: COMPARATOR
Intervention: Corn-soy blend (CSB)
Number of subjects: 1609
Study 33003086 — intervention group
Group type: EXPERIMENTAL
Intervention: DA+ (islet amyloid positive)
Number of subjects: 120
Study 33003086 — intervention group
Group type: EXPERIMENTAL
Intervention: DA- (islet amyloid negative)
Number of subjects: 120
Study 33003086 — intervention group
Group type: COMPARATOR
Intervention: ND (nondiabetic controls)
Number of subjects: 120
Study 33003086 — intervention group
Group type: EXPERIMENTAL
Intervention: DA+
Number of subjects: 120
Study 33003086 — intervention group
Group type: EXPERIMENTAL
Intervention: DA-
Number of subjects: 120
Study 33003086 — intervention group
Group type: COMPARATOR
Intervention: ND
Number of subjects: 120
Study 33003086 — intervention group
Group type: EXPERIMENTAL
Intervention: Interlobar arteriosclerosis
Number of subjects: 120
Study 36209381 — intervention group
Group type: EXPERIMENTAL
Intervention: Fractional CO2 laser treatment followed by topical application of triamcinolone acetonide
Number of subjects: 30
Study 36209381 — intervention group
Group type: COMPARATOR
Intervention: Dermapen treatment followed by topical application of triamcinolone acetonide
Number of subjects: 30
Study 36209381 — intervention group
Group type: COMPARATOR
Intervention: Microneedling
Number of subjects: 30
Study 36209381 — intervention group
Group type: EXPERIMENTAL
Intervention: Fractional CO2 laser
Number of subjects: 30
Study 33956794 — intervention group
Group type: EXPERIMENTAL
Intervention: Environmental concern
Number of subjects: 400
Study 33956794 — intervention group
Group type: EXPERIMENTAL
Intervention: Functional and emotional values
Number of subjects: 400
Study 35188180 — intervention group
Group type: EXPERIMENTAL
Intervention: Ixekizumab 80 mg every 2 weeks (IXEQ2W)
Number of subjects: 567
Study 35188180 — intervention group
Group type: EXPERIMENTAL
Intervention: Ixekizumab 80 mg every 4 weeks (IXEQ4W)
Number of subjects: 567
Study 35188180 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PBO)
Number of subjects: 567
Study 34281470 — intervention group
Group type: EXPERIMENTAL
Intervention: ramucirumab + erlotinib
Number of subjects: 0
Study 34281470 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 0
Study 32927753 — intervention group
Group type: EXPERIMENTAL
Intervention: Highly cooked potato (HP) + rice (HP + R)
Number of subjects: 17
Study 32927753 — intervention group
Group type: EXPERIMENTAL
Intervention: Minimally cooked potato (MP) + rice (MP + R)
Number of subjects: 17
Study 32927753 — intervention group
Group type: EXPERIMENTAL
Intervention: Preload of HP prior to rice meal (PHP + R)
Number of subjects: 17
Study 32927753 — intervention group
Group type: EXPERIMENTAL
Intervention: Preload of MP prior to rice meal (PMP + R)
Number of subjects: 17
Study 32927753 — intervention group
Group type: EXPERIMENTAL
Intervention: Partially hydrolyzed guar gum (HG) + HP + rice (HG + HP + R)
Number of subjects: 17
Study 32927753 — intervention group
Group type: EXPERIMENTAL
Intervention: Preload of HG prior to co-ingestion of HP and rice (PHG + HP + R)
Number of subjects: 17
Study 32927753 — intervention group
Group type: EXPERIMENTAL
Intervention: Co-preload of HG and HP prior to rice (PHG + PHP + R)
Number of subjects: 17
Study 32927753 — intervention group
Group type: EXPERIMENTAL
Intervention: Preload of HP prior to co-ingestion of HG and rice (PHP + HG + R)
Number of subjects: 17
Study 33719795 — intervention group
Group type: EXPERIMENTAL
Intervention: Digital Cognitive Behavioral Therapy for Insomnia (CBTI)
Number of subjects: 46
Study 33481328 — intervention group
Group type: EXPERIMENTAL
Intervention: sorafenib + vitamin K2 (menatetrenone, 45 mg daily, orally)
Number of subjects: 44
Study 33481328 — intervention group
Group type: COMPARATOR
Intervention: sorafenib only
Number of subjects: 44
Study 34296646 — intervention group
Group type: EXPERIMENTAL
Intervention: Perceived harsh ecological condition
Number of subjects: 1098
Study 34296646 — intervention group
Group type: COMPARATOR
Intervention: Perceived safe ecological condition
Number of subjects: 1098
Study 35904046 — intervention group
Group type: EXPERIMENTAL
Intervention: Esketamine nasal spray (ESK) plus standard of care (SoC)
Number of subjects: 362
Study 35904046 — intervention group
Group type: COMPARATOR
Intervention: Placebo nasal spray (PBO) plus standard of care (SoC)
Number of subjects: 362
Study 33844425 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate intervention group (theory-based health information technology intervention)
Number of subjects: 60
Study 33844425 — intervention group
Group type: COMPARATOR
Intervention: Waitlist control group (routine care for the first 3 months)
Number of subjects: 60
Study 33844425 — intervention group
Group type: COMPARATOR
Intervention: Waitlist control group (after crossover to intervention)
Number of subjects: 60
Study 34574433 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical activity and psychological modification-based intervention
Number of subjects: 60
Study 34574433 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 60
Study 33009265 — intervention group
Group type: EXPERIMENTAL
Intervention: Bupivacaine pudendal block
Number of subjects: 90
Study 33009265 — intervention group
Group type: COMPARATOR
Intervention: Normal saline (control)
Number of subjects: 90
Study 33153484 — intervention group
Group type: EXPERIMENTAL
Intervention: interprof ACT intervention package for 12 months
Number of subjects: 680
Study 33153484 — intervention group
Group type: COMPARATOR
Intervention: care as usual (control group)
Number of subjects: 680
Study 32598909 — intervention group
Group type: EXPERIMENTAL
Intervention: Vaginal progesterone 600 mg per day from 11 to 14 until 34 weeks’ gestation
Number of subjects: 1194
Study 32598909 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1194
Study 32598909 — intervention group
Group type: EXPERIMENTAL
Intervention: Vaginal progesterone
Number of subjects: 1194
Study 34719731 — intervention group
Group type: EXPERIMENTAL
Intervention: THC 8 mg
Number of subjects: 36
Study 34719731 — intervention group
Group type: EXPERIMENTAL
Intervention: CBD 400 mg
Number of subjects: 36
Study 34719731 — intervention group
Group type: EXPERIMENTAL
Intervention: THC 8 mg + CBD 4 mg (THC + CBDlow)
Number of subjects: 36
Study 34719731 — intervention group
Group type: EXPERIMENTAL
Intervention: THC 12 mg + CBD 400 mg (THC + CBDhigh)
Number of subjects: 36
Study 34719731 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36
Study 32497599 — intervention group
Group type: EXPERIMENTAL
Intervention: MT10107 (Coretox®)
Number of subjects: 220
Study 32497599 — intervention group
Group type: COMPARATOR
Intervention: onabotulinum toxin A (Botox®)
Number of subjects: 220
Study 35296214 — intervention group
Group type: EXPERIMENTAL
Intervention: Pivotal Response Treatment (PRT)
Number of subjects: 20
Study 35296214 — intervention group
Group type: COMPARATOR
Intervention: Treatment as Usual (TAU)
Number of subjects: 20
Study 32438716 — intervention group
Group type: EXPERIMENTAL
Intervention: Photobiomodulation therapy (PBMT) with laser irradiation, applied on days 0, 3, 7, and 14 for 2-4 minutes each session
Number of subjects: 6
Study 32438716 — intervention group
Group type: COMPARATOR
Intervention: Placebo (non-irradiated group)
Number of subjects: 6
Study 32438716 — intervention group
Group type: EXPERIMENTAL
Intervention: Photobiomodulation therapy (PBMT)
Number of subjects: 6
Study 36046945 — intervention group
Group type: EXPERIMENTAL
Intervention: Hybrid care modality
Number of subjects: 121
Study 36046945 — intervention group
Group type: COMPARATOR
Intervention: Face-to-face consultation
Number of subjects: 121
Study 33973828 — intervention group
Group type: EXPERIMENTAL
Intervention: Photobiomodulation therapy using 660, 800, and 970 nm wavelengths with 30 kJ of energy for 3 minutes
Number of subjects: 11
Study 33973828 — intervention group
Group type: COMPARATOR
Intervention: Standard of care for wound management
Number of subjects: 11
Study 35146847 — intervention group
Group type: EXPERIMENTAL
Intervention: Neuropsychiatric Inventory Questionnaire (NPI‐Q)
Number of subjects: 161
Study 35146847 — intervention group
Group type: EXPERIMENTAL
Intervention: NPI‐Q scores
Number of subjects: 161
Study 35146847 — intervention group
Group type: EXPERIMENTAL
Intervention: NPI‐Q domains (anxiety, apathy/indifference, aberrant motor behaviours, appetite/eating disturbance)
Number of subjects: 161
Study 35146847 — intervention group
Group type: EXPERIMENTAL
Intervention: Years of education
Number of subjects: 161
Study 35146847 — intervention group
Group type: COMPARATOR
Intervention: Living together
Number of subjects: 161
Study 34193163 — intervention group
Group type: EXPERIMENTAL
Intervention: Recommended diets
Number of subjects: 0
Study 34193163 — intervention group
Group type: COMPARATOR
Intervention: Current diet
Number of subjects: 0
Study 34193163 — intervention group
Group type: EXPERIMENTAL
Intervention: Government supplements due to SARS-CoV-2 pandemic
Number of subjects: 0
Study 33210772 — intervention group
Group type: EXPERIMENTAL
Intervention: Risk indicator - Smoking
Number of subjects: 99
Study 33210772 — intervention group
Group type: EXPERIMENTAL
Intervention: Risk indicator - Moderate/severe periodontitis
Number of subjects: 99
Study 33210772 — intervention group
Group type: EXPERIMENTAL
Intervention: Risk indicator - <16 remaining teeth
Number of subjects: 99
Study 33210772 — intervention group
Group type: EXPERIMENTAL
Intervention: Risk indicator - Plaque
Number of subjects: 99
Study 33210772 — intervention group
Group type: EXPERIMENTAL
Intervention: Risk indicator - Implant malposition (too vestibular)
Number of subjects: 99
Study 33210772 — intervention group
Group type: EXPERIMENTAL
Intervention: Risk indicator - Implant brand (Nobel vs. Straumann)
Number of subjects: 99
Study 33210772 — intervention group
Group type: EXPERIMENTAL
Intervention: Risk indicator - Restoration type (bridge vs. single crown)
Number of subjects: 99
Study 33210772 — intervention group
Group type: EXPERIMENTAL
Intervention: Risk indicator - Trauma as reason of tooth loss (vs. caries)
Number of subjects: 99
Study 33210772 — intervention group
Group type: EXPERIMENTAL
Intervention: Protective indicator - Interproximal flossing/brushing
Number of subjects: 99
Study 33210772 — intervention group
Group type: EXPERIMENTAL
Intervention: Protective indicator - Proton pump inhibitors
Number of subjects: 99
Study 33210772 — intervention group
Group type: EXPERIMENTAL
Intervention: Protective indicator - Anticoagulants
Number of subjects: 99
Study 35570493 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotic Bifidobacterium breve MCC1274 (2×10^10 CFU)
Number of subjects: 130
Study 35570493 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 130
Study 34636710 — intervention group
Group type: EXPERIMENTAL
Intervention: System-based intervention (individualized health education, diabetes prevention booklet, postpartum booster educational program including dietary and exercise counseling)
Number of subjects: 298
Study 34636710 — intervention group
Group type: COMPARATOR
Intervention: Standard treatment (group therapy on diet and physical activity modification)
Number of subjects: 298